Alarin regulates RyR2 and SERCA2 to improve cardiac function in heart failure with preserved ejection fraction
European Journal of Histochemistry · 2024
DOI: 10.4081/ejh.2024.4122 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Histochemistry, 2024. Verfasst von Jinshuang Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Suqian Hospital Affiliated of Xuzhou Medical University, Nanjing Drum Tower Hospital Group Suqian Hospital, Suqian, Jiangsu. Hauptthemen laut MEDLINE: Heart Failure, Ryanodine Receptor Calcium Release Channel, Sarcoplasmic Reticulum Calcium-Transporting ATPases, Stroke Volume. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure with preserved ejection fraction (HFpEF), a complex disease that is increasingly prevalent due to population aging, pose significant challenges in its treatment. The present study utilized the HFpEF rat model and H9C2 cells as research subjects to thoroughly investigate the potential mechanisms of alarin in protecting cardiac function in HFpEF. The study shows that under HFpEF conditions, oxidative stress significantly increases, leading to myocardial structural damage and dysfunction of calcium ion channels, which ultimately impairs diastolic function. Alarin, through its interaction with NADPH oxidase 1 (NOX1), effectively alleviates oxidative stress and modulates the activities of type 2 ryanodine receptor (RyR2) and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2), thereby facilitating the restoration of Ca2+ homeostasis and significantly improving cardiac function in the HFpEF model. This research not only uncovers the cardioprotective effects of alarin and its underlying molecular mechanisms but also provides new insights and potential therapeutic targets for HFpEF treatment strategies, suggesting a promising future for alarin and related therapies in the management of this debilitating condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Suqian Hospital Affiliated of Xuzhou Medical University, Nanjing Drum Tower Hospital Group Suqian Hospital, Suqian, Jiangsu.
- Department of Emergency Intensive Care Unit, Suqian Hospital Affiliated of Xuzhou Medical University, Nanjing Drum Tower Hospital Group Suqian Hospital, Suqian, Jiangsu.
- Department of Orthopedics, Suqian Hospital Affiliated of Xuzhou Medical University, Nanjing Drum Tower Hospital Group Suqian Hospital, Suqian, Jiangsu.
- Department of Cardiology, Suqian Zhongwu Hospital, Suqian, Jiangsu.
ORCID-Profile: Yong Cheng
Zitieren
APA
Li, J., Xu, D., Shi, C., Cheng, C., Xu, Z., Gao, X., & Cheng, Y. (2024). Alarin regulates RyR2 and SERCA2 to improve cardiac function in heart failure with preserved ejection fraction. European Journal of Histochemistry. https://doi.org/10.4081/ejh.2024.4122
Vancouver
Li J, Xu D, Shi C, Cheng C, Xu Z, Gao X, et al. Alarin regulates RyR2 and SERCA2 to improve cardiac function in heart failure with preserved ejection fraction. European Journal of Histochemistry. 2024. doi:10.4081/ejh.2024.4122
BibTeX
@article{Li2024,
author = {Li, Jinshuang and Xu, Dawei and Shi, Ce and Cheng, Chunqi and Xu, Ziheng and Gao, Xingjuan and Cheng, Yong},
title = {Alarin regulates RyR2 and SERCA2 to improve cardiac function in heart failure with preserved ejection fraction},
journal = {European Journal of Histochemistry},
year = {2024},
doi = {10.4081/ejh.2024.4122}
}
EUVIMED